Effect of EDTA and PYP as Co-Ligand of Radiolabeled Nanomaterial M41S-NH₂ for Radiosynovectomy

Abstract:

Radiosynovectomy is an innovative medical treatment for rheumatoid arthritis joints. A small amount of beta-emitting radiopharmaceutical is injected into the joint with intra-articullar route of administration. An ideal radionuclide for this treatment is beta emitter whose minimal gamma ray emission, tissue penetration between 5 10 mm, has short half life, high chemical purity and non-toxic properties such as Rhenium-188. For delivering the radionuclide to the specific target site in the synovial tissue and preventing the leakage to the lymph, an ideal carrier as particulate or colloidal compounds is requaired. A silica-based nanomaterial called M41S-NH₂ was developed as therapeutic carriers by Polytechnic Institute of Nuclear Technology, Yogyakarta. The advantage of M41S-NH₂ is biocompatible and not toxic to human body. As a preliminary experiment, M41S-NH₂ was labeled using Technetium-99m which has a similar chemical properties with Rhenium-188. The radiolabelling performed in this system is the indirect method. The purpose of this research is to obtain the highest radiochemical purity of radiolabeled ^99mTc-M41S-NH₂ by using two co-ligands such as ethylenediaminetetraasetic acid (EDTA) and sodium pyophosphate (PYP). Some parameter such as pH, ratio of SnCl₂ to co-ligand, ammount of reductor agent, ammount of M41S-NH₂ were optimized in those experiments. Radiochemical purity determination was conducted by ascending paper chromatography method using Whatman 31-ET as stationary phase and physiological saline (NaCl 0,9%) as mobile phase. The optimum condition obtained from the investigation were by using 10 μg PYP as co-ligand, 10 μg SnCl₂ as reductor agent, pH 9, and 10 minutes in room temperature as incubation time. More over the highest radiochemical purity obtained from those labeling experiments is 93.42± 0.06 %.

• Periodical: Advanced Materials Research (Volume 896)
• Pages: 687-694
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.896.687
• Online since: February 2014
• Authors: Isti Daruwati, Maria P. Christina, Wahyu W. Perdana, Nugrahaning Wuri Hakiki, Nanny Kartini Oekar*
• Keywords: Co-Ligand, EDTA, Nanomaterial M4IS-NH₂, PYP, Radiosynovectomy, Technetium-99m

References

[1] International Association for the Study of Pain (IASP), International Association for the Study of Pain 2009 Annual Report, 2009, cited http: /www. iasp-pain. org.

[2] World Health Organization, Chronic rheumatic conditions, http: /www. who. int/ chp/topics/rheumatic.

[3] Nainggolan O, 2009, Prevalensi dan Determinan Penyakit Rematik di Indonesia, Majalah Kedokteran Indonesia, 59(12): 588-594.

[4] http: /www. kalbe. co. id/printed-cdk/139/sendi-dan-tulang. html, download April (2013).

[5] Scott D.L., Wolfe F., and Huizinga W.J.T., 2010, Rheumatoid Arthritis, Lancet 376: 1094–1108.

DOI: 10.1016/s0140-6736(10)60826-4

[6] Kempen WU, Brenner W, Czech N, and Henze E., 2002, Intraarticular application ofunsealed beta-emitting radionuclides in the treatment course of inflammatory joint diseases, Curr Med Chem, 1(1): 77-87.

DOI: 10.2174/1568014024606502

[7] Schneider P, Farahati J, Reiners C., 2005, Radiosynovectomy in Rheumatology, Orthopedics, and Hemophilia, J Nucl Med. 46: 48s–54s.

[8] Kresge, C. T., Leonowicz, M. E., Roth, W. J., Vartuli, J. C., and Beck, J. S., 1992, Ordered Mesoporous Molecular Sieves Synthesized by a Liquid-Crystal Templat Mechanism, Nature 359, pp.710-713.

DOI: 10.1038/359710a0

[9] Beck, J.S., Roth, Vartuli, W.J., Leonowies, M. E, Kresge, C.T., Schmitt, K.D., Chu, G.T.W., Olson, D.H., Sheppard, E.W., Mc Cullen, S.B., Higgins and J.B., Schlenher, J.L., 1992, A New Family of Mesoporous Molecular Sieves Prepared with Liquid Cristal. American Journal of Chemical Society.

DOI: 10.1021/ja00053a020

[10] Pedernera M., de la Iglesia O., Mallada R. , Coronas J. , and Santamaría J., 2003. Preparation of Tubular MCM-48 Membranes, Enpomer, 2nd Mercosur Congress on Chemical Engineering biopolymer.

DOI: 10.1016/j.memsci.2008.09.050

[11] Wieslaw J. R., and Sewell, N.J., 2000, Synthesis of The Cubic Mesoporous Molecular Sieve MCM-48, Mobil Oil Corporation, US Patent No. US006096288A.

[12] Wani A, Muthuswamy E, Savithra G. H, Mao G, Brock S, and Oupický D. 2012, Surface Functionalization of Mesoporous Silica Nanoparticles Controls Loading and Release Behavior of Mitoxantrone, Pharm Res. [Epub ahead of print US], National Library of Medicine National Institutes of Health.

DOI: 10.1007/s11095-012-0766-9

[13] Christina M. P, 2011, Pembuatan MCM-48 Tercangkok Gugus Amine Dari Silika Limbah Padat Geotermal Untuk Penjerap CO2, Tesis Pasca Sarjana Prodi Teknik Kimia, MTPPL UGM.

[14] Saha, GB. Fundamentals of Nuclear Pharmacy, Fifth Edition. Springer, New York. (2004).

[15] Mi-Sun Pyun, Kang-Hyuk Choi, Young-Don Hong, and Sun-Ju Choi, 2009, Synthesis of Bifunctional Chelating Agent Derived from Lysine and its Radiolabeling with 99mTc Bull. Korean Chem. Soc. 30(5)1187.

DOI: 10.5012/bkcs.2009.30.5.1187

[16] IAEA. 2008. Technical Reports Series No. 466. Technetium-99m Radiopharmaceuticals : Manufacture Of Kits. Vienna.

[17] Welch MJ, Redvanly CS. 2003. Handbook of Radiopharmaceuticals: Radiochemistry and Applications. John Wiley and Sons. England.

[18] Kim JR. Awh O. 1980. Studies on The Formation of Pyrophosphate-99mTc Complex. Journal of The Korean Nuclear Society. 12(1): 19-28.

[19] Yewle, Jivan N., 2012, Bifunctional Bisphosphonates For Delivering Biomolecules To Bone, Theses and Dissertations-Chemistry, University of Kentucky.